Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00119002 · ClinicalTrials.gov registry record · Phase 4

The Effectiveness of Oral Dexamethasone for Acute Bronchiolitis

A Phase 4 study of Bronchiolitis, Viral, sponsored by University of Utah.

Completed
Registry status
Phase 4
Development phase
598
Enrollment target
1
Study location

NCT00119002 is a Phase 4 study of Bronchiolitis, Viral that has completed, run by University of Utah. The registered enrollment target is 598 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00119002, a Phase 4 study of Bronchiolitis, Viral, has completed, sponsored by University of Utah.

COMPLETED
Registry status
Phase 4
Development phase
598 participants
Enrollment target
1
Study location

Study Summary

This study will compare a single dose of oral dexamethasone to placebo in a multicenter, randomized, double blind trial of infants aged 2 to 12 months with first-time bronchiolitis (defined as wheezing within 7 days of onset). This is given as additional therapy beyond any other routine therapy used at that center. No current standard therapy is withheld, and no additional tests or other treatments are part of the study.The primary hypothesis is that dexamethasone will be more effective than placebo in preventing hospital admission. The secondary hypotheses are that dexamethasone will decrease respiratory scores and possibly the duration of the disease when compared to placebo, and that dexamethasone will be as safe and as well tolerated as placebo.

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG dexamethasone

Study Locations (1)

Utah

  • Primary Children's Medical Center - Salt Lake City

Trial Details

FieldValue
Enrollment Target 598 participants
Start Date 2004-01
Est. Completion 2006-04
Phase Phase 4

Sponsor

University of Utah

818 total trials

What the Registry Record Tells You About NCT00119002

The ClinicalTrials.gov registry entry for NCT00119002 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 598 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Bronchiolitis, Viral appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00119002 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT00119002 about?

NCT00119002 is a clinical study titled "The Effectiveness of Oral Dexamethasone for Acute Bronchiolitis". This study will compare a single dose of oral dexamethasone to placebo in a multicenter, randomized, double blind trial of infants aged 2 to 12 months with first-time bronchiolitis (defined as wheezing within 7 days of onset). This is given as additional therapy beyond any other routine therapy used...

What is the current status of trial NCT00119002?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 598 participants. The study started on 2004-01. Estimated completion is 2006-04.

What conditions does trial NCT00119002 study?

This clinical trial studies the following conditions: Bronchiolitis, Viral.

What interventions are being tested in trial NCT00119002?

The interventions under investigation include: Placebo (DRUG), dexamethasone (DRUG).

Who is sponsoring clinical trial NCT00119002?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00119002 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bronchiolitis, Viral

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.